Biohaven Pharmaceuticals is flexing its migraine share leapfrog over powerhouse AbbVie—thanks to Nurtec ODT’s dual acute-plus-prevention nod and an aggressive digital-first strategy. Digital ads across …
There’s a shifting focus in pharma public relations from image to impact, says Ogilvy Health’s new PR practice president. Shannon Walsh, recently tapped to lead …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
